Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 93

1.

The margin of safety of a single application of transdermal fentanyl solution when administered at multiples of the therapeutic dose to laboratory dogs.

Savides MC, Pohland RC, Wilkie DA, Abbott JA, Newbound GC, Freise KJ, Clark TP.

J Vet Pharmacol Ther. 2012 Aug;35 Suppl 2:35-43. doi: 10.1111/j.1365-2885.2012.01410.x.

PMID:
22731774
[PubMed - indexed for MEDLINE]
2.

Pharmacokinetics and dose selection of a novel, long-acting transdermal fentanyl solution in healthy laboratory Beagles.

Freise KJ, Savides MC, Riggs KL, Owens JG, Newbound GC, Clark TP.

J Vet Pharmacol Ther. 2012 Aug;35 Suppl 2:21-6. doi: 10.1111/j.1365-2885.2012.01399.x.

PMID:
22731772
[PubMed - indexed for MEDLINE]
3.

Naloxone reversal of an overdose of a novel, long-acting transdermal fentanyl solution in laboratory Beagles.

Freise KJ, Newbound GC, Tudan C, Clark TP.

J Vet Pharmacol Ther. 2012 Aug;35 Suppl 2:45-51. doi: 10.1111/j.1365-2885.2012.01409.x.

PMID:
22731775
[PubMed - indexed for MEDLINE]
4.

Pharmacokinetics and the effect of application site on a novel, long-acting transdermal fentanyl solution in healthy laboratory Beagles.

Freise KJ, Newbound GC, Tudan C, Clark TP.

J Vet Pharmacol Ther. 2012 Aug;35 Suppl 2:27-33. doi: 10.1111/j.1365-2885.2012.01411.x.

PMID:
22731773
[PubMed - indexed for MEDLINE]
5.

The effectiveness of a long-acting transdermal fentanyl solution compared to buprenorphine for the control of postoperative pain in dogs in a randomized, multicentered clinical study.

Linton DD, Wilson MG, Newbound GC, Freise KJ, Clark TP.

J Vet Pharmacol Ther. 2012 Aug;35 Suppl 2:53-64. doi: 10.1111/j.1365-2885.2012.01408.x.

PMID:
22731776
[PubMed - indexed for MEDLINE]
6.

Population pharmacokinetics of transdermal fentanyl solution following a single dose administered prior to soft tissue and orthopedic surgery in dogs.

Freise KJ, Linton DD, Newbound GC, Tudan C, Clark TP.

J Vet Pharmacol Ther. 2012 Aug;35 Suppl 2:65-72. doi: 10.1111/j.1365-2885.2012.01407.x.

PMID:
22731777
[PubMed - indexed for MEDLINE]
7.

The history and pharmacology of fentanyl: relevance to a novel, long-acting transdermal fentanyl solution newly approved for use in dogs.

Kukanich B, Clark TP.

J Vet Pharmacol Ther. 2012 Aug;35 Suppl 2:3-19. doi: 10.1111/j.1365-2885.2012.01416.x. Review.

PMID:
22731771
[PubMed - indexed for MEDLINE]
8.

Accidental prehension and suspected transmucosal or oral absorption of fentanyl from a transdermal patch in a dog.

Schmiedt CW, Bjorling DE.

Vet Anaesth Analg. 2007 Jan;34(1):70-3.

PMID:
17238966
[PubMed - indexed for MEDLINE]
9.

Pharmacokinetics of fentanyl following intravenous and transdermal administration in horses.

Maxwell LK, Thomasy SM, Slovis N, Kollias-Baker C.

Equine Vet J. 2003 Jul;35(5):484-90.

PMID:
12875327
[PubMed - indexed for MEDLINE]
10.

A novel long-acting transdermal fentanyl solution for dogs. Editorial.

Riviere JE.

J Vet Pharmacol Ther. 2012 Aug;35 Suppl 2:1. doi: 10.1111/j.1365-2885.2012.01417.x. No abstract available.

PMID:
22731770
[PubMed - indexed for MEDLINE]
11.

The cardiorespiratory effects of a fentanyl infusion following acepromazine and glycopyrrolate in dogs.

Lemmens S, Stienen PJ, Jaramillo LG, Doornenbal A, Hellebrekers LJ.

Tijdschr Diergeneeskd. 2008 Nov 1;133(21):888-95.

PMID:
19040085
[PubMed - indexed for MEDLINE]
12.

Use of TTS fentanyl as a single opioid for cancer pain relief: a safety and efficacy clinical trial in patients naive to mild or strong opioids.

Mystakidou K, Befon S, Tsilika E, Dardoufas K, Georgaki S, Vlahos L.

Oncology. 2002;62(1):9-16.

PMID:
11810038
[PubMed - indexed for MEDLINE]
13.

Comparison of plasma fentanyl concentrations by using three transdermal fentanyl patch sizes in dogs.

Egger CM, Duke T, Archer J, Cribb PH.

Vet Surg. 1998 Mar-Apr;27(2):159-66.

PMID:
9525032
[PubMed - indexed for MEDLINE]
14.

Evaluation of analgesic effect and safety of fentanyl transdermal patch for cancer pain as the first line.

Hoya Y, Okamoto T, Yanaga K.

Support Care Cancer. 2010 Jun;18(6):761-4. doi: 10.1007/s00520-010-0869-y. Epub 2010 Mar 31.

PMID:
20354734
[PubMed - indexed for MEDLINE]
15.

Transdermal fentanyl. A review of its pharmacological properties and therapeutic efficacy in pain control.

Jeal W, Benfield P.

Drugs. 1997 Jan;53(1):109-38. Review.

PMID:
9010652
[PubMed - indexed for MEDLINE]
16.

Dose proportionality of fentanyl buccal tablet in doses ranging from 600 to 1300 microg in healthy adult subjects: a randomized, open-label, four-period, crossover, single-centre study.

Darwish M, Kirby M, Robertson P Jr, Tracewell W, Xie F.

Clin Drug Investig. 2010;30(6):365-73. doi: 10.2165/11533360-000000000-00000.

PMID:
20441245
[PubMed - indexed for MEDLINE]
17.

Efficacy, safety and pharmacokinetic study of a novel fentanyl-containing matrix transdermal patch system in Japanese patients with cancer pain.

Miyazaki T, Hanaoka K, Namiki A, Ogawa S, Kitajima T, Hosokawa T, Ishida T, Nogami S, Mashimo S.

Clin Drug Investig. 2008;28(5):313-25.

PMID:
18407717
[PubMed - indexed for MEDLINE]
18.

Use of transdermal fentanyl without prior opioid stabilization in patients with cancer pain.

Tawfik MO, Bryuzgin V, Kourteva G; FEN-INT-20 Study Group.

Curr Med Res Opin. 2004 Mar;20(3):259-67.

PMID:
15025835
[PubMed - indexed for MEDLINE]
19.
20.

Pharmacokinetics of fentanyl after intravenous and transdermal administration in goats.

Carroll GL, Hooper RN, Boothe DM, Hartsfield SM, Randoll LA.

Am J Vet Res. 1999 Aug;60(8):986-91.

PMID:
10451210
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk